Anybody know how involved taking Campath off label would be? I am guessing we are talking something more involved than getting a shot at the doctor's office? Days in the hospital? Cost?

Thanks,
Looking88

Are the best candidates for Campath young people with highly inflamatory MS?

I am hoping it has worked for those with few or no lesions also.

Thanks,
Looking88

Hello all,
I haven't really been on here for a while. Mostly because for the past two years my symptoms had quieted down and I was busy living an active life. I've been in the campath study for three years now. As I'd hoped for, I responded pretty well to the first two doses; (well not to the actual infusions they almost killed me) but once my body healed I felt like I might be ...

Genzyme which plans to announce pivotal results from its program evaluating Campath in multiple sclerosis later this year, is also interested in broadening its portfolio in this indication, said Dr Michael Panzara.

The company remains committed to researching the drug’s effect on the autoimmune system in light of certain side-effects seen in trials, said Panzara, who is group vice president of multiple sclerosis and immune diseases at Genzyme.

Campath (alemtuzumab) is a chemotherapy drug ...

April 14, 2011 12:00 PM Eastern Daylight Time 

Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease

Data Presented at 63rd Annual Meeting of the American Academy Of Neurology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp., a subsidiary of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), today reported additional five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial showing that nearly two-thirds of alemtuzumab treated patients remained free of ...

Genzyme, a subsidiary of sanofi-aventis Group announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis (MS) at the American Academy of Neurology's (AAN) 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.

Included among the additional Phase 2 trial safety and efficacy data at AAN will be presentations on the clinically-active disease status of patients through five-years of patient follow-up ...

Ggenzyme’s experimental ms drug to profit investors only if it has success.
<shortened url>

anyone else been offered an extension for the campath clinical trial? genzyme wants to do yearly infusions now. any info would be good, i am setting up for my next infusion in end of april. this will be number three for me the initial 5day dose, followed by 3day dose. then i guess this will be a maintenance dosing..

I went in for the monthly blood draw and urine sample deposit and got a call that I have to go back to get my urine checked again. They detected protein in it and want to retest to see if it's still there. Has any other campather had this happen? Anybody know what it might mean in regard to campath? I didn't think it's a symptom listed for ITP.

quick up-date...sorry for delay but had 2nd round campath on the 25th of August, body reacted better this time BUT just had a bad relapse about Nov 25th or 26th it started...this one was the wort yet....had 5 day's of sol-u-med, because of the holiday, had 2 days skipped one had another one skipped two days and then 2 more...coming out of it but not sure what to expect when sol-u-med wears off.. think relapse ...